Pharmacy Tech Scholar
OCTOBER 18, 2021
PTCB Announces Point-of-Care Testing Certificate Earlier this week, the Pharmacy Technician Certification Board (PTCB) announced the availability of the Point-of-care Testing Certificate for pharmacy technicians. The creation… The post PTCB Announces Point-of-Care Testing Certificate appeared first on PharmacyTechScholar.com.
pharmaphorum
OCTOBER 19, 2021
The work of the UK’s HTA body, the National Institute for Health and Care Excellence (NICE), is often heatedly debated, and this time it’s for holding back a clinical guideline. Leela Barham looks into the controversy. Updating a previous clinical guideline. NICE began their work to update a 2007 clinical guideline on Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in January 2018.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
OCTOBER 21, 2021
Microsoft integrates healthcare cloud service with Cerner EHR for smoother telehealth visits. rtorrence. Thu, 10/21/2021 - 16:10.
Outsourcing Pharma
OCTOBER 19, 2021
To fully reap the benefits of tech advances, a company leader advises, a life-sciences firm must embrace change and connection throughout the operation.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Mirror
OCTOBER 22, 2021
ADELAIDE, AUS, Oct 19, 2021 – (ACN Newswire) – Agilex Biolabs, the Australian regulated bioanalytical and toxicology laboratory facilities for clinical trials is presenting a new webinar entitled “Getting it right! Considerations for Immuno-oncology and Vaccine Studies and the Bioanalytical Tools used” in partnership with Outsourcing Clinical Trials (OCT).
pharmaphorum
OCTOBER 22, 2021
The FDA has approved an artificial intelligence-based test for early detection of dementia that can be carried out on an iPad in five minutes. The CognICA Integrated Cognitive Assessment (ICA) test developed by London, UK-based company Cognetivity Neurosciences has been approved by the FDA as an alternative to traditional pen-and-paper tests with some key advantages, according to its developer.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Outsourcing Pharma
OCTOBER 18, 2021
According to the firm, infectious-disease research advancements could be applied to discovering treatments for millions of hepatitis patients globally.
Pharma Mirror
OCTOBER 22, 2021
New Delhi, India, More than 50 per cent of the world’s hip fractures are expected to occur in the Asia Pacific by the year 2050. In a strong effort to stem the tide, and to promote quality care in osteoporosis, the Asia Pacific Consortium on Osteoporosis (APCO) has launched a world-first, interactive, educational osteoporosis resource – the APCO Health Care Professional (HCP) Peer to Peer Educational Modules – today, to mark World Osteoporosis Day (Wednesday, October 20).
pharmaphorum
OCTOBER 21, 2021
Twitter has been used by health professionals for over a decade to share medical knowledge and education. Until late-2018 they had only 140 characters to do this, increasing to 280 at that time. There have been some collaborative ways to have meaningful interactions on the platform including Twitter journal clubs. Four ways HCPs are using Twitter for medical education.
Fierce Healthcare
OCTOBER 22, 2021
23andMe jumps into telehealth, prescription drug delivery with $400M buyout of Lemonaid Health. hlandi. Fri, 10/22/2021 - 10:44.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Outsourcing Pharma
OCTOBER 18, 2021
A leader from the drug development and manufacturing firm talks about the ways in which advanced digital tools stand to revolutionize the pharma field.
Pharma Mirror
OCTOBER 22, 2021
TOKYO, Hitachi, Ltd. (TSE: 6501), Tohoku University and Kyoto University have become the world’s first (1) to establish technology for the highly efficient and high-quality production of actinium-225 (225Ac), a substance required for a form of radiation therapy known as targeted alpha therapy (TAT). TAT is a new cancer therapy which combines a substance that emits alpha particles which destroy cancer cells with a compound that selectively accumulates in cancer cells.
pharmaphorum
OCTOBER 19, 2021
A new poll of clinical trial sponsors has found that around nine out of 10 of them are running decentralised trials with the help of digital technologies, a big increase on pre-COVID-19 levels. The survey by Veeva Systems found a big increase in the adoption of technologies that enabled remote trials during COVID-19, with increased use of tools such as remote monitoring, electronic data collection and consent forms, and web portals for studies.
Fierce Healthcare
OCTOBER 22, 2021
Volumes for these elective procedures are closest to rebounding from COVID declines, Epic finds. agliadkovskaya. Fri, 10/22/2021 - 16:43.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Outsourcing Pharma
OCTOBER 18, 2021
A study from Climedo Health aims at revealing the growing influence the decentralized format is enjoying across the industry and what might lie ahead.
Pharma Mirror
OCTOBER 21, 2021
Post-workout protein intake has numerous benefits. For a long time, fitness experts and nutritionists have recommended taking protein after your workout. Though the health benefits of pre-workout protein intake are in question, the post-workout protein intake helps recover muscle after intense exercise. A pre-training shake is a drink that you can consume before any workout or physical activity to improve the body’s performance.
pharmaphorum
OCTOBER 18, 2021
Roche has claimed an earlier-than-expected FDA approval for its checkpoint inhibitor Tecentriq in non-small cell lung cancer (NSCLC), giving the drug a lead in early-stage cases that can be treated with surgery. The US regulator has cleared Tecentriq (atezolizumab) as adjuvant treatment after surgery and platinum-based chemotherapy in patients with tumours in which 1% or more cells express the PD-L1 biomarker, to try to stop the cancer recurring.
Fierce Healthcare
OCTOBER 18, 2021
HLTH21: Grand Rounds Health, Doctor on Demand rebrand combined company as Included Health. pminemyer. Mon, 10/18/2021 - 07:30.
Turnkey Pharmacy Solutions
OCTOBER 19, 2021
Written By Chelsea Violette and Matt Parker Compliance is the foundation of a successful 340B program and, rightfully so, is the primary focus for most 340B covered entities. Often, this focus consumes most available staff and resources, leaving terms like optimization and augmentation not only feeling nebulous and out of reach, but also as though.
Outsourcing Pharma
OCTOBER 21, 2021
This monthâs list of partnerships, manufacturing facilities, new technologies and other items includes AstraZeneca, Charles River, Veeva, and other firms.
pharmaphorum
OCTOBER 21, 2021
Analysts were predicting sales of Biogen’s recently approved Alzheimer’s therapy Aduhelm may start to gather a little momentum in the third quarter, but the drug seems to be going into reverse. As it turned out, Aduhelm (aducanumab) made just $300,000 in the three-month period from July to September, against analysts’ estimates of $12 million, suggesting that few patients are being treated with the $56,000 a year therapy.
Fierce Healthcare
OCTOBER 18, 2021
HLTH21: DeSalvo says baking health into all Google's efforts opens the door to 'billions' of healthy consumers. dmuoio. Mon, 10/18/2021 - 00:59.
Med Ed 101
OCTOBER 20, 2021
CA is a 58-year-old female with CKD. Her CrCL today is 45 mL/min and stable sCr of 1.3 mg/dL. She complains of muscle aches that started a couple of weeks ago and that her doctor said she can’t use NSAIDs, even though the Tylenol doesn’t completely help the pain. She also reports new mild diarrhea […]. The post Case Study – Diarrhea and Achiness appeared first on Med Ed 101.
Outsourcing Pharma
OCTOBER 19, 2021
The University of California at Irvine and the data firm will work on solutions that help integrate health data for both clinical trials and patient care.
pharmaphorum
OCTOBER 22, 2021
In the latest Health Innovators video chat, pharmaphorum’s founder, Dr Paul Tunnah, chats with the founder and CEO of digital mental health pioneer Healios. Rich Andrews explains his background in big pharma and his inspiration for moving into the start-up space with Healios and its focus on mental health and neurodiverse conditions for children and adolescents.
Fierce Healthcare
OCTOBER 20, 2021
HLTH21: Traditional healthcare is missing younger consumers. How can providers win them back? dmuoio. Wed, 10/20/2021 - 17:11.
Med Ed 101
OCTOBER 17, 2021
Statin myopathy is a primary reason why patients stop taking these cholesterol-lowering medications. Here’s a case scenario where I discuss considerations and options to addressing statin myopathy and adverse effect concerns from a patient. SE is a 58-year-old obese male with diabetes and an LDL of 186. The primary provider elected to start atorvastatin 20 […].
Outsourcing Pharma
OCTOBER 21, 2021
The Distributed Pharmaceutical Analysis Lab and the blockchain-based platform provider will work to prevent fake and low-quality drugs from circulating.
pharmaphorum
OCTOBER 22, 2021
Sanofi and Regeneron’s Dupixent has become the first biologic drug to show activity in prurigo nodularis (PN), raising the hope of a new treatment option for the rare and highly debilitating skin disease. The two companies are still waiting for the results of a second phase 3 trial, due in the first half of next year, but if that is positive expect to file for approval of Dupixent (dupilumab) in the new indication before the end of 2022.
Fierce Healthcare
OCTOBER 21, 2021
Report: Most Medicare beneficiaries receive telehealth services from providers they know. pminemyer. Thu, 10/21/2021 - 15:43.
Pharma Times
OCTOBER 21, 2021
Givlaari uses ‘gene silencing’ RNA interference technology, to target the production of pathogenic compounds in people AHP
Outsourcing Pharma
OCTOBER 21, 2021
With the launch of its Trialbee Honey technology, the company aims to bring together recruitment information from different sources for sweeter results.
pharmaphorum
OCTOBER 22, 2021
Merck & Co’s Keytruda become the first cancer immunotherapy to be approved as a first-line oesophageal cancer treatment in the EU earlier this year, but will now face competition from Bristol-Myers Squibb’s Opdivo. The European Commission has given a green light to Opdivo (nivolumab) with chemotherapy for previously-untreated patients with HER2-negative oesophageal, gastric and gastroesophageal junction (GEJ) cancer whose tumours express the PDL-1 biomarker with a score of five o
Fierce Healthcare
OCTOBER 18, 2021
HLTH21: Health systems targeting disparities should include community projects in their investment portfolios. dmuoio. Sun, 10/17/2021 - 22:05.
Expert insights. Personalized for you.
221 
Let's personalize your content